CARE Ratings downgrades Themis Medicare to CARE BB+

What happened

Themis Medicare (THEMISMED) told the exchanges on 30 September 2026 at 07:15 PM that CARE Ratings has downgraded its credit rating to CARE BB+.

From the filing: "Crore) Rating Remarks Long Term Bank Facilities 77.39 CARE BB+;"

Company snapshot

Themis Medicare is a small-cap company, with a market value of about ₹1,076 crore.

The stock last traded at ₹116.9, against a 52-week range of ₹64.95–₹147 (20.5% below the high).

Before this filing the shares had moved −6.9% over the month and +5.6% over three months. Average daily turnover over the last 20 sessions was about ₹4.51 crore.

Promoters held 67.11% at the end of Q1 FY27; 43.39% of promoter shares were pledged. Foreign institutions owned 0.01% and domestic institutions 0.01%.

What history shows

BCEIE has no earlier credit rating filing from this company on record since May 2026.

Market-wide, 1,190 credit rating filings with an impact score of 50 or more saw an average next-day move of +0.2%, with 48% rising.

Past reactions describe what happened before; they are not a forecast.

What to watch

• Any change in borrowing costs, covenants or further rating actions.

In the news

Recent coverage elsewhere (links open the original publisher):

• Themis Medicare Returns to Profit in FY26, Recommends Dividend of Re. 0.50 Per Share — scanx.trade, 27 Sept 2026
• Themis Medicare GUJTHEM 56th AGM Resolutions Passed — Kalkine India, 30 Sept 2026
• Themis Medicare withdraws ₹47 crore preferential issue plan — scanx.trade, 24 Sept 2026
• Themis Medicare AGM 2026: Key Resolutions Passed — Kalkine India, 30 Sept 2026
• Themis Medicare shareholders adopt FY26 financials at 56th AGM — scanx.trade, 30 Sept 2026

Source

• Exchange filing (PDF)